Tweets
Dr Weber would add low dose #colchicine in pts who are at very high CV risk. Be careful with pts who have CKD #RNL2024 @rheumnow https://t.co/k00vqiQlI5
TheDaoIndex @KDAO2011 ( View Tweet )
2 years ago
Useful resource on dietary guidance in RA from @ACRheum focusing on a MD-like diet #RNL2024 @RheumNow https://t.co/QplaQ1caxv.
Dr. Antoni Chan @synovialjoints ( View Tweet )
2 years ago
An amazing handout showing Art of communicating risk and benefit with our patients to promote shared decision making.
Will defiantly start using it in my clinic.
Hani El Gabalawy.
#RNL2024
@RheumNow https://t.co/Gl7uUCQbnv
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Vit d and omega 3 reduces incidence of RA.
Hani El Gabalawy.
#RNL2024
@RheumNow https://t.co/BGGbLvMhhT
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Good number of ACPA positive patients reverts to ACPA negative in 5 years.
Hani El Gabalawy.
#RNL2024
@RheumNow https://t.co/yLxO0ulsam
Nouf Al hemmadi @NoufAhmedAlham2 ( View Tweet )
2 years ago
Dr. Kavanaugh: "Role of alcohol on inflammation? It's part of the Mediterranean diet!"
Dr. Guma:"The data is mixed; polyphenols may be beneficial; alcohol in limited quantities was allowed in studies"
Dr. Weber:" Be careful w/EtOH in pts w/palpitations"
#RNL2024 @rheumnow
TheDaoIndex @KDAO2011 ( View Tweet )
2 years ago
Do you use the ASA24?
Dr. Gabalawy asked Dr. Guma about this index at the #RNL2024. These indices don't quite encompass all aspects of the ACR recommended Mediterranean diet, for example, but could be useful in developing better assessments for patients and their diet.… https://t.co/v4Fu43u7et https://t.co/CTV2IaJ1xW
Links:
Dr. Rachel Tate @uptoTate ( View Tweet )
2 years ago
Panel discussion online and in person on #rheumatoidarthritis #RNL2024 Dr. Weber discusses with Dr. Guma, Dr. Gabalawy and @rheumnow ways to assess CV risk in patients by looking at family history, inflammation, comorbidities, imaging studies https://t.co/yM58kvr7CR
TheDaoIndex @KDAO2011 ( View Tweet )
2 years ago
Happening Now! RheumNowLive @RheumNow
Stil time to register and join; only $105 for fellows!
Clinically focused & high yield; check it out! https://t.co/ADTEbsJrxP
Mike Putman @EBRheum ( View Tweet )
2 years ago
How do you communicate risk/benefit to patients? @RADoctor's recent publication highlighted by Dr. H. Gabalawy at #RNL2024 @RheumNow
1. Increase awareness
2. Include numbers for context
3. Make it easy for patients to understand those numbers
4. Use absolute risks
5. Avoid 1 in… https://t.co/DqmgD2j5Wp https://t.co/v6CQAX9YRr
Links:
Dr. Rachel Tate @uptoTate ( View Tweet )
2 years ago
Managing patients with clinically suspect arthritis (CSA), <20% of ACPA positive patients without arthralgia develop RA in 5 years, Hani El Gabalwy #RNL2024 @RheumNow https://t.co/RKaDsozhXl
Dr. Antoni Chan @synovialjoints ( View Tweet )
2 years ago
Per this study: 40% of pts had RA at 5 years and 40% were seronegative at 5 years. (See red line box) Interesting finding from Dr. H. Gabalawy #RNL2024 @RheumNow https://t.co/m5zJkDO2bk
Dr. Rachel Tate @uptoTate ( View Tweet )
2 years ago
